Project description
A practical allergen biosensor makes life easier for food allergy sufferers
Changes in lifestyle and nutrition have an impact on our immunological responses to food. Therefore, there is a growing need for easy-to-use tools for allergen detection aimed at food allergy sufferers. The EU-funded SensoGenic project aims at developing an innovative consumer product that detects milk and eggs simultaneously in relevant food and concentrations. This food allergen biosensor is a portable, handheld, digital diagnostic analyser based on advanced nanotechnology science and patents to accurately measure specific proteins of interest. SensoGenic aspires to upgrade the life quality of food allergy sufferers and their families.
Objective
SensoGenic Ltd. is a science and technology company based in Israel, that is developing food allergens biosensor which is
a portable, handheld, a digital diagnostic analyser for consumers. https://www.sensogenic.com Today, there isn't any
consumer solution in the market that address food allergens detection. The solution for food manufactures is very long and
expensive laboratory tests. SensoGenic will focus on consumer product that detects milk and eggs simultaneously in
relevant food and concentrations. After successfully validating the POC of SensoGenic, based on company own research
and experiments as well as supportive academic articles, the team can confirm the capability of its breakthrough IP as
unique approach for allergens proteins detection. By pursuing the present feasibility study, the management team aims to
improve its understanding of international market conditions and the associated risks that need to be considered as the
company develops a deeper business plan for rolling out, and scaling up SensoGenic as a marketable innovative solution.
SME Instrument Phase-1 and Phase-2 will be extremely beneficial in helping the company to accelerate development and
market penetration of the solution in target segments, boosting the company’s growth to 100 employees and €26,000,000
revenues by 2025.
Fields of science
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorsbiosensors
- engineering and technologyother engineering and technologiesfood technology
- medical and health sciencesclinical medicineallergologyfood allergy
- medical and health sciencesclinical medicineemergency medicine
- medical and health sciencesbasic medicineimmunology
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
7628210 REHOVOT
Israel
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.